RAPT Therapeutics Inc. (RAPT)
NASDAQ: RAPT
· Real-Time Price · USD
1.23
0.37 (43.34%)
At close: May 23, 2025, 3:59 PM
1.19
-3.25%
After-hours: May 23, 2025, 05:58 PM EDT
43.34% (1D)
| Bid | 1.16 |
| Market Cap | 162.72M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -116.51M |
| EPS (ttm) | -2.48 |
| PE Ratio (ttm) | -0.5 |
| Forward PE | -1.56 |
| Analyst | Hold |
| Ask | 1.21 |
| Volume | 4,248,634 |
| Avg. Volume (20D) | 815,607 |
| Open | 0.86 |
| Previous Close | 0.86 |
| Day's Range | 0.84 - 1.23 |
| 52-Week Range | 0.71 - 4.60 |
| Beta | -0.04 |
About RAPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RAPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RAPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+110.81%
RAPT Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
6 months ago
-39.45%
RAPT Therapeutics shares are trading lower after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.
